Author

Subrata Ghosh

USTEKINUMAB THERAPY AFTER BIOLOGIC FAILURE IN PATIENTS WITH CROHN’S DISEASE – A REAL-WORLD SINGLE CENTRE EXPERIENCE
USTEKINUMAB THERAPY AFTER BIOLOGIC FAILURE IN PATIENTS WITH CROHN’S DISEASE – A REAL-WORLD SINGLE CENTRE EXPERIENCE

Subrata Ghosh  et al.

EFFECTS OF OZANIMOD ON CIRCULATING LYMPHOCYTES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: FLOW CYTOMETRY RESULTS FROM THE STEPSTONE PHASE 2 STUDY
EFFECTS OF OZANIMOD ON CIRCULATING LYMPHOCYTES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: FLOW CYTOMETRY RESULTS FROM THE STEPSTONE PHASE 2 STUDY

Subrata Ghosh  et al.

RECAPTURE OF RESPONSE WITH OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO WITHDREW THERAPY: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
RECAPTURE OF RESPONSE WITH OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO WITHDREW THERAPY: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

Subrata Ghosh  et al.

EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDERS TO OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDERS TO OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

Subrata Ghosh  et al.

RESPONSE TO BIOLOGICS IN IBD PATIENTS ASSESSED BY COMPUTERIZED IMAGE ANALYSIS OF PROBE BASED CONFOCAL LASER ENDOMICROSCOPY WITH MOLECULAR LABELING
RESPONSE TO BIOLOGICS IN IBD PATIENTS ASSESSED BY COMPUTERIZED IMAGE ANALYSIS OF PROBE BASED CONFOCAL LASER ENDOMICROSCOPY WITH MOLECULAR LABELING

Subrata Ghosh  et al.

THE CROHN’S DISEASE THERAPEUTIC DIET INTERVENTION (CD-TDI) FOR REDUCING INFLAMMATION IN MILD-MODERATELY ACTIVE CROHN’S DISEASE: A PRELIMINARY ANALYSIS
THE CROHN’S DISEASE THERAPEUTIC DIET INTERVENTION (CD-TDI) FOR REDUCING INFLAMMATION IN MILD-MODERATELY ACTIVE CROHN’S DISEASE: A PRELIMINARY ANALYSIS

Subrata Ghosh  et al.

REAL WORLD USE OF THE IBD DISK TOOL IN UNSELECTED COHORTS OF OUTPATIENTS
REAL WORLD USE OF THE IBD DISK TOOL IN UNSELECTED COHORTS OF OUTPATIENTS

Subrata Ghosh  et al.

NOVEL SERUM SOLUBLE MARKERS OF HISTOLOGICAL HEALING IN ULCERATIVE COLITIS
NOVEL SERUM SOLUBLE MARKERS OF HISTOLOGICAL HEALING IN ULCERATIVE COLITIS

Subrata Ghosh  et al.

REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD
REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD

Subrata Ghosh  et al.

REAL-WORLD EFFECTIVENESS AND SAFETY OF COMBINATION BIOLOGICS AND SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE – A MULTICENTRE STUDY
REAL-WORLD EFFECTIVENESS AND SAFETY OF COMBINATION BIOLOGICS AND SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE – A MULTICENTRE STUDY

Subrata Ghosh  et al.

EFFECT OF OZANIMOD TREATMENT AND DISCONTINUATION ON ABSOLUTE LYMPHOCYTE COUNT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A PHASE 3 RANDOMIZED TRIAL
EFFECT OF OZANIMOD TREATMENT AND DISCONTINUATION ON ABSOLUTE LYMPHOCYTE COUNT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A PHASE 3 RANDOMIZED TRIAL

Subrata Ghosh  et al.

EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE THROUGH 5 YEARS: FINAL RESULTS FROM THE IM-UNITI LONG-TERM EXTENSION
EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE THROUGH 5 YEARS: FINAL RESULTS FROM THE IM-UNITI LONG-TERM EXTENSION

Subrata Ghosh  et al.

MAINTENANCE OF WEEK 12 RESPONSES THROUGH WEEK 52 WITH ETRASIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 3 ELEVATE UC 52 TRIAL
MAINTENANCE OF WEEK 12 RESPONSES THROUGH WEEK 52 WITH ETRASIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 3 ELEVATE UC 52 TRIAL

Subrata Ghosh  et al.

GENE EXPRESSION PROFILING IN ULCERATIVE COLITIS IDENTIFIES CHARACTERISTICS FOR ANTI-TNF RESPONSE AND TARGETS FOR ALTERNATIVE THERAPIES
GENE EXPRESSION PROFILING IN ULCERATIVE COLITIS IDENTIFIES CHARACTERISTICS FOR ANTI-TNF RESPONSE AND TARGETS FOR ALTERNATIVE THERAPIES

Subrata Ghosh  et al.

NEUTROPHIL-ONLY HISTOLOGICAL ASSESSMENT OF ULCERATIVE COLITIS CORRELATES WITH ENDOSCOPIC ACTIVITY AND PREDICTS LONG-TERM OUTCOMES IN A MULTICENTER STUDY
NEUTROPHIL-ONLY HISTOLOGICAL ASSESSMENT OF ULCERATIVE COLITIS CORRELATES WITH ENDOSCOPIC ACTIVITY AND PREDICTS LONG-TERM OUTCOMES IN A MULTICENTER STUDY

Subrata Ghosh  et al.

AN ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT HISTOLOGICAL REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS PATIENTS
AN ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT HISTOLOGICAL REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS PATIENTS

Subrata Ghosh  et al.

A VIRTUAL CHROMOENDOSCOPY ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT ENDOSCOPIC AND HISTOLOGIC ACTIVITY/REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS
A VIRTUAL CHROMOENDOSCOPY ARTIFICIAL INTELLIGENCE SYSTEM TO DETECT ENDOSCOPIC AND HISTOLOGIC ACTIVITY/REMISSION AND PREDICT CLINICAL OUTCOMES IN ULCERATIVE COLITIS

Subrata Ghosh  et al.

Item 21 - 37 / 37
1
2